Provided by:
Radiation Oncology Weekly Chart
Rounds
2016
Radiation Oncology Weekly Chart Rounds
January 8, 2016
12:00-1:00 PM
TH
PCAM 4 Floor Board Room and Radiation Oncology 2 West Conference Room
Alexander Lin, MD, Gary Freedman, MD and Charles Simone, MD
University of Pennsylvania
3400 Civic Center Blvd.
Philadelphia, PA 19104
Target Audience
This program has been designed for physicians, fellows, residents, medical students, physician assistants, professional
nurses, advanced practice nurses in the medical specialties of radiation oncology.
Series Educational Objectives
After completing this activity, participants should be able to:
 Based on diagnosis and clinical indications, determine appropriate doses/volumes/techniques for radiation
therapy for patients treated with radiation
 Identify radiation dose tolerances for organs at risk (OARs) in order to deliver radiation safely to minimize risk of
damage to normal tissues
 Promote communication between nurses and physicians regarding likely side effects and their management in
patients undergoing radiation therapy based on evaluation of treatment plans
Accreditation
Physicians: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council
for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nurses: The Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional
Development is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited
approver by the American Nurses Credentialing Center's Commission on Accreditation.
Designation of Credit
Physicians: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a
maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of
their participation in the activity.
Nurses: Nurse participants will be awarded 1.0 contact hour.
Approved for (PSRM) patient safety/risk management designation
Acknowledgement of Commercial Support* NONE
For more information, please contact
Nancy Beatty
215-360-0960
Nancy.beatty@uphs.upenn.edu
Check your CME online at www.penncmeonline.com
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania and the Hospital of the University of Pennsylvania, Department of
Nursing Education, Innovation and Professional Development for individuals who are in a position to control the content of an educational activity
to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that
may be relevant to the content of this continuing education activity. For this purpose we consider relationships of the person involved to include
financial relationships of a spouse or partner.
The intent of this policy is to ensure that Penn CME/CNE certified activities promote quality and safety, are effective in improving medical practice,
are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was
conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant
to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based
presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, CHCP, FACEHP, Director of
CME, Zalman Agus, MD, Senior peer reviewer and Patricia A. Smith, MSN, RN-BC, Nursing professional development specialist of the HUP
Department of Nursing Innovation and Development have disclosed that they have no relevant financial relationships with any commercial
interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of
this educational activity:
PLANNING COMMITTEE MEMBER & PRESENTER NAME
ROBERT LUSTIG, MD, FACR
GARY FREEDMAN, MD
CHARLES SIMONE, MD
ERIN DAVIS, MSN, CRNP
PRESENTER NAME
CHRISTOPHER AINSLEY
MICHELLE ALONSO-BASANTA SHIBU ANANAJAYIL, MS
NATHAN ANDERSON
BRIAN BAUMANN
MARC BELLERIVE MSC DABR EDGAR BEN-JOSEF, MD
ABIGAIL BERMAN, MD
ALEJANDRO CARABE-FERNANDEZ
HANN-HSING CHAO
QING CHEN
ERIN L. DAVIS, MSN, CRNP DEREK DOLNEY
HANG DONG
JAY DORSEY
GARY FREEDMAN
SAUMIL GANDHI
ELIZABETH GARVER, MD
CHRISTOPHER GALLAGHER GEOFFREY GEIGER, MD
BRETT HARTL
KENITH L. HOGUE
KEVIN JONES
OWEN KENTAN
CHRISTOPHER KENNEDY
JAMES KOLKER
HRIBO LIN, PHD
WILLIAM LEVIN
LIYONG LIN
RICHARD MAUGHAN
SUNEEL NAGDA
KEVIN NEAD
ERIC OJERHOLM
ARTHUR OLSZANSKI
JOHN PLASTARAS
RYAN SCHEUREMANN
JACOB SHABASON
SONAM SHARMA
CHARLES SIMONE II, MD
DAVID SUTTON
KEVCIN TEO
REID THOMPSON, MD
PATRICK TRIPP
GILMER VALDES
NEHA VAPIWALA
CATHERINE WALSH
KRISTINA WOODHOUSE
CHUAN ZENG
HUIFANG ZHAI
JUSTIN BEKELMAN
ET-TSU CHEN, MD
JAROD FINLAY
SURBHI GROVER
MAURA KIRK
JAMES MCDONOUGH
WILLIAM RATE, MD
SAMUEL SWISHER-MCCLURE
JENNIFER VOGEL
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this
educational activity.
PLANNING COMMITTEE MEMBER & PRESENTER NAME
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
Alexander Lin, MD
IBA
Speaker
Elekta
Consultant
Amit Maity, MD, PHD
Merck
PI Clinical Trial
Timothy Solberg, PhD
Global Radiosurgery
Owner/Partner
Varian & IBA
Advisor
PRESENTER NAME
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
JOHN CHRISTODOULEAS
ELEKTA, AB
EMPLOYMENT
JOEL GOLDWEIN
ELEKTA
SPEAKER
ANDRE KONSKI
VARIAN MEDICAL SYSTEM & US ONCOLOGY/MCKESSON
SPEAKER
LILIE LIN
VARIAN
RESEARCH
Relevant financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights,
consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other
financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including
contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other
activities from which remuneration is received or expected
DISCLOSURE OF UNAPPROVED USES OF PRODUCTS
PRESENTER NAME
PRODUCT
INVESTIGATIONAL AND/OR OFF-LABEL USE